The role of TNF-a in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

Abstract

The recent insight that inflammation contributes to the development of atherosclerosis and type 2 diabetes mellitus constitutes a major breakthrough in understanding the mechanisms underlying these conditions. In addition, it opens the way for new therapeutic approaches that might eventually decrease the prevalence of these public health problems. Tumor necrosis factor-a (TNF-a) has been shown to play a key role in these processes and thus might be a potential therapeutic target. Increased concentrations of TNF-a are found in acute and chronic inflammatory conditions (e.g., trauma, sepsis, infection, rheumatoid arthritis), in which a shift toward a proatherogenic lipid profile and impaired glucose tolerance occurs. Although therapeutic blockade of TNF-a worsens the prognosis in patients with abscesses and granulomatous infections, this strategy is highly beneficial in the case of chronic inflammatory conditions, including rheumatoid arthritis. Current investigations assessing the impact of anti-TNF agents on intermediary metabolism suggest that TNF-a blockade may improve insulin resistance and lipid profiles in patients with chronic inflammatory diseases.—Popa, C., M. G. Netea, P. L. C. M. van Riel, J. W. M. van der Meer, and A. F. H. Stalenhoef. The role of TNF-a in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J. Lipid Res. 2007. 48: 751–762. Supplementary key words tumor necrosis factor-a & lipids & anti-tumor necrosis factor & insulin resistance

Extracted Key Phrases

5 Figures and Tables

020040020072008200920102011201220132014201520162017
Citations per Year

1,926 Citations

Semantic Scholar estimates that this publication has 1,926 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Popa2007TheRO, title={The role of TNF-a in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk}, author={Calin D. Popa and Mihai G. Netea and Piet L. C. M. van Riel and Jos W . M . van der Meer and Anton F. H. Stalenhoef}, year={2007} }